TY  - JOUR
AU  - Jakszyn, Paula
AU  - Fonseca-Nunes, Ana
AU  - Lujan-Barroso, Leila
AU  - Aranda, Núria
AU  - Tous, Mónica
AU  - Arija, Victoria
AU  - Cross, Amanda
AU  - Bueno-de-Mesquita, H B As
AU  - Weiderpass, Elisabete
AU  - Kühn, Tilman
AU  - Kaaks, Rudolf
AU  - Sjöberg, Klas
AU  - Ohlsson, Bodil
AU  - Tumino, Rosario
AU  - Palli, Domenico
AU  - Ricceri, Fulvio
AU  - Fasanelli, Francesca
AU  - Krogh, Vittorio
AU  - Mattiello, Amalia
AU  - Jenab, Mazda
AU  - Gunter, Marc
AU  - Perez-Cornago, Aurora
AU  - Khaw, Kay-Tee
AU  - Tjønneland, Anne
AU  - Olsen, Anja
AU  - Overvad, Kim
AU  - Trichopoulou, Antonia
AU  - Peppa, Eleni
AU  - Vasilopoulou, Effie
AU  - Boeing, Heiner
AU  - Sánchez-Cantalejo, Emilio
AU  - Huerta, José María
AU  - Dorronsoro, Miren
AU  - Barricarte, Aurelio
AU  - Quirós, José Maria
AU  - Peeters, Petra H
AU  - Agudo, Antonio
PY  - 2017
DO  - 10.1002/ijc.30797
UR  - http://hdl.handle.net/10668/11238
T2  - International journal of cancer
AB  - Hepcidin is the main regulator of iron homeostasis and dysregulation of proteins involved in iron metabolism has been associated with tumorogenesis. However, to date, no epidemiological study has researched the association between hepcidin levels and...
LA  - en
KW  - cohort study
KW  - gastric cancer
KW  - hepcidin
KW  - iron homeostasis
KW  - Adenocarcinoma
KW  - Case-Control Studies
KW  - Chromatography, Liquid
KW  - Cohort Studies
KW  - Female
KW  - Ferritins
KW  - Hepcidins
KW  - Humans
KW  - Male
KW  - Mass Spectrometry
KW  - Odds Ratio
KW  - Risk Factors
KW  - Stomach Neoplasms
TI  - Hepcidin levels and gastric cancer risk in the EPIC-EurGast study.
TY  - research article
VL  - 141
ER  -